NWG vs TRV
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
NWG presents a stark contrast between deep value and deteriorating fundamental health. While the stock trades significantly below its Graham Number ($22.92) and Intrinsic Value ($48.5), the Piotroski F-Score of 2/9 indicates severe weakness in financial health and operational efficiency. Strong dividend yields and low P/E ratios are offset by a bearish technical trend and poor fundamental momentum. The investment case relies on a value-recovery thesis, but the low health score suggests significant underlying risks.
TRV presents a stable financial profile with a Piotroski F-Score of 4/9, indicating a stable but not strong health trajectory. The stock is currently trading almost exactly at its Graham Number ($305.57), suggesting it is fairly valued from a defensive standpoint, despite a much higher growth-based intrinsic value. While earnings growth and ROE are impressive, the outlook is dampened by bearish insider activity and a very weak technical trend. The company remains a solid value play, but lacks immediate bullish catalysts.
Compare Another Pair
Related Comparisons
NWG vs TRV: Head-to-Head Comparison
This page compares NatWest Group plc (NWG) and The Travelers Companies, Inc. (TRV) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.